20-Year Risks of Breast-Cancer Recurrence after Stopping Endocrine Therapy at 5 Years

Overview of attention for article published in New England Journal of Medicine, November 2017

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (99th percentile)
High Attention Score compared to outputs of the same age and source (97th percentile)

Mentioned by

news: 154 news outlets
blogs: 4 blogs
policy: 3 policy sources
twitter: 328 X users

patent: 2 patents
facebook: 22 Facebook pages
googleplus: 2 Google+ users
reddit: 1 Redditor

Citations

dimensions_citation: 993 Dimensions

Readers on

mendeley: 963 Mendeley
citeulike: 3 CiteULike

Summary News Blogs Policy documents X Patents Facebook Google+ Reddit Dimensions citations

So far, Dimensions has found 993 publications that cite this research output.

993

The most recent citing publications are shown below. View all 993 publications that cite this research output on Dimensions.

Development and validation of a circulating tumor cells-related signature focusing on biochemical recurrence and immunotherapy response in prostate cancer

Article in Heliyon (December 2023)

Treatment of residual disease following neoadjuvant therapy in breast cancer

Article in Journal of Surgical Oncology (November 2023)

Adjuvant CDK4/6 Inhibitors for Early Breast Cancer: How to Choose Wisely?

Article in Oncology and Therapy (November 2023)